Exchange: NASDAQ·Updated 09:54 AM EST

LKFT Lakefront Biotherapeutics NV - ADR

$35.49
$2.15
(6.43%)
Today
EarningsFeb 24
Mkt Cap$2.19B
Vol70,794.00

About LKFT

Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
38

Bearish Sentiment

How do you feel about LKFT?

Advertisement|Remove ads.